ATOX1 and cancer: In addition to ATOX1, investigation of the potential of other copper transporters and chaperones in siRNA therapy of NSCLC and other cancers, such as ATP7B in ovarian cancer (28) and ATP7A in neuroblastoma (29) is warranted.